238 related articles for article (PubMed ID: 28450112)
21. Neddylation Inhibition Activates the Extrinsic Apoptosis Pathway through ATF4-CHOP-DR5 Axis in Human Esophageal Cancer Cells.
Chen P; Hu T; Liang Y; Li P; Chen X; Zhang J; Ma Y; Hao Q; Wang J; Zhang P; Zhang Y; Zhao H; Yang S; Yu J; Jeong LS; Qi H; Yang M; Hoffman RM; Dong Z; Jia L
Clin Cancer Res; 2016 Aug; 22(16):4145-57. PubMed ID: 26983464
[TBL] [Abstract][Full Text] [Related]
22. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
[TBL] [Abstract][Full Text] [Related]
23. MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies.
Kuo KL; Ho IL; Shi CS; Wu JT; Lin WC; Tsai YC; Chang HC; Chou CT; Hsu CH; Hsieh JT; Chang SC; Pu YS; Huang KH
Cancer Lett; 2015 Jul; 363(2):127-36. PubMed ID: 25615422
[TBL] [Abstract][Full Text] [Related]
24. The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.
Zhao L; Yue P; Lonial S; Khuri FR; Sun SY
Mol Cancer Ther; 2011 Dec; 10(12):2415-25. PubMed ID: 21914854
[TBL] [Abstract][Full Text] [Related]
25. Neddylation inhibitor, MLN4924 suppresses angiogenesis in huvecs and solid cancers:
Shi CS; Kuo KL; Lin WC; Chen MS; Liu SH; Liao SM; Hsu CH; Chang YW; Chang HC; Huang KH
Am J Cancer Res; 2020; 10(3):953-964. PubMed ID: 32266102
[TBL] [Abstract][Full Text] [Related]
26. Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924).
Wong KM; Micel LN; Selby HM; Tan AC; Pitts TM; Bagby SM; Spreafico A; Klauck PJ; Blakemore SJ; Smith PF; McDonald A; Berger A; Tentler JJ; Eckhardt SG
Invest New Drugs; 2017 Feb; 35(1):11-25. PubMed ID: 27783255
[TBL] [Abstract][Full Text] [Related]
27. The NEDD8-activating enzyme inhibitor MLN4924 induces G2 arrest and apoptosis in T-cell acute lymphoblastic leukemia.
Han K; Wang Q; Cao H; Qiu G; Cao J; Li X; Wang J; Shen B; Zhang J
Oncotarget; 2016 Apr; 7(17):23812-24. PubMed ID: 26993774
[TBL] [Abstract][Full Text] [Related]
28. MLN4924 therapy as a novel approach in cancer treatment modalities.
Oladghaffari M; Islamian JP; Baradaran B; Monfared AS
J Chemother; 2016 Apr; 28(2):74-82. PubMed ID: 26292710
[TBL] [Abstract][Full Text] [Related]
29. The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice.
Yu H; Luo H; Chang L; Wang S; Geng X; Kang L; Zhong Y; Cao Y; Wang R; Yang X; Zhu Y; Shi MJ; Hu Y; Liu Z; Yin X; Ran Y; Yang H; Fan W; Zhao BQ
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35101976
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of SAG E3 ubiquitin ligase blocks embryonic stem cell differentiation and sensitizes leukemia cells to retinoid acid.
Tan M; Li Y; Yang R; Xi N; Sun Y
PLoS One; 2011; 6(11):e27726. PubMed ID: 22110742
[TBL] [Abstract][Full Text] [Related]
31. Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis.
Zhao Y; Xiong X; Jia L; Sun Y
Cell Death Dis; 2012 Sep; 3(9):e386. PubMed ID: 22951983
[TBL] [Abstract][Full Text] [Related]
32. Neddylation-Independent Activities of MLN4924.
Mao H; Sun Y
Adv Exp Med Biol; 2020; 1217():363-372. PubMed ID: 31898238
[TBL] [Abstract][Full Text] [Related]
33. AKT inhibitor MK-2206 sensitizes breast cancer cells to MLN4924, a first-in-class NEDD8-activating enzyme (NAE) inhibitor.
Chen X; Cui D; Bi Y; Shu J; Xiong X; Zhao Y
Cell Cycle; 2018; 17(16):2069-2079. PubMed ID: 30198810
[TBL] [Abstract][Full Text] [Related]
34. Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity.
Jia X; Li C; Li L; Liu X; Zhou L; Zhang W; Ni S; Lu Y; Chen L; Jeong LS; Yu J; Zhang Y; Zhang J; He S; Hu X; Sun H; Yu K; Liu G; Zhao H; Zhang Y; Jia L; Shao ZM
Clin Cancer Res; 2019 Jun; 25(12):3658-3672. PubMed ID: 30833270
[TBL] [Abstract][Full Text] [Related]
35. Neddylation inhibition upregulates PD-L1 expression and enhances the efficacy of immune checkpoint blockade in glioblastoma.
Zhou S; Zhao X; Yang Z; Yang R; Chen C; Zhao K; Wang W; Ma Y; Zhang Q; Wang X
Int J Cancer; 2019 Aug; 145(3):763-774. PubMed ID: 31044422
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of neddylation by MLN4924 improves neointimal hyperplasia and promotes apoptosis of vascular smooth muscle cells through p53 and p62.
Ai TJ; Sun JY; Du LJ; Shi C; Li C; Sun XN; Liu Y; Li L; Xia Z; Jia L; Liu J; Duan SZ
Cell Death Differ; 2018 Feb; 25(2):319-329. PubMed ID: 29027989
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Mcl-1 enhances Pevonedistat-triggered apoptosis in osteosarcoma cells.
Zhang Y; Shi C; Yin L; Zhou W; Wang H; Seng J; Li W
Exp Cell Res; 2017 Sep; 358(2):234-241. PubMed ID: 28663057
[TBL] [Abstract][Full Text] [Related]
38. The NEDD8-activating enzyme inhibition with MLN4924 sensitizes human cancer cells of different origins to apoptosis and necroptosis.
El-Mesery M; Anany MA; Hazem SH; Shaker ME
Arch Biochem Biophys; 2020 Sep; 691():108513. PubMed ID: 32721435
[TBL] [Abstract][Full Text] [Related]
39. The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme.
Yang D; Tan M; Wang G; Sun Y
PLoS One; 2012; 7(3):e34079. PubMed ID: 22457814
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting Neddylation with MLN4924 Suppresses Growth and Delays Multicellular Development in
Huber RJ; Kim WD; Mathavarajah S
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33807046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
